News 4: UT Health looking for participants in Phase 3 Novavax COVID vaccine trial

Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study.

Read the story.

Share This Article!